Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Limbal stem cell transplantation restores the corneal surface when native stem cells are deficient. Reported outcomes are favorable in many centers, especially with controlled inflammation and careful selection. Results vary by technique, cause of disease, and the need for immune suppression with donor tissue. Long-term follow-up monitors clarity, comfort, and graft survival.
read more about limbal stem cell transplant success rate ...Auto-grafts avoid immune rejection and often have stronger durability when feasible. Allografts require immune control and closer monitoring. Pre-operative surface optimization improves healing. Combined approaches with scleral lenses or keratoplasty are used when indicated.
Many patients achieve a stable, comfortable surface with improved vision quality. Success depends on etiology, inflammation control, and adherence to care. Center experience and technique selection matter. Numbers vary across studies and time frames.
Rejection, infection, and recurrence of the original disease can threaten the graft. Systemic medicines for allografts carry side effects. Close follow-up detects problems early. Plans include rescue strategies if issues arise.
People with confirmed limbal stem cell deficiency that fails medical care are considered. Bilateral disease may need donor tissue if no autograft source exists. Active inflammation is treated before surgery. Goals and expectations are reviewed in detail.
Recovery is gradual with careful protection of the ocular surface. Frequent visits and medication adjustments are common early on. Vision improves as the epithelium stabilizes and smooths. Supportive lenses and lubrication add comfort.
Limbal stem cell transplantation is indicated in severe limbal stem cell deficiency caused by chemical or thermal burns, Stevens?Johnson syndrome, ocular cicatricial pemphigoid or multiple unsuccessful corneal transplants.
Possible complications include graft rejection, infection, inflammation and recurrence of the underlying disease. Long-term immunosuppression may be necessary for allogeneic transplants.
Recovery can take several months. Patients need close follow-up to monitor epithelialization, control inflammation and ensure graft survival.